Find NINDS Clinical Trials

Study Title Sort descending Disorders Status Study Location Clinical Trials ID
Vasodilation in Patients With Fabry's Disease Fabry Disease Completed Maryland NCT00001774
Ventricular Size Involvement in Neuropsychological Outcomes in Pediatric Hydrocephalus Hydrocephalus Completed Multiple U.S. Locations NCT01797627
VERiTAS II REFRESHED Stroke Not Yet Recruiting Illinois NCT03729817
Vertebrobasilar Flow Evaluation and Risk of Transient Ischemic Attack and Stroke (VERiTAS) Stroke Completed Multiple U.S. Locations NCT00590980
Vibration for Muscle Spasms After Spinal Cord Injury Recruiting Illinois NCT03598504
Vietnam Head Injury Study - Phase III Traumatic Brain Injury (TBI) Completed Maryland NCT00132249
Vigor and the LDR in Parkinson Disease Recruiting Michigan NCT04821830
Viral Suppression After Analytic Treatment Interruption in Thai Patients Who Initiated Highly Active Antiretroviral Therapy During Acute HIV Infection Completed NCT02614950
Visualization of Cerebral Arteries Using Contrast-Enhanced Transcranial Ultrasound in Stroke Patients Stroke Terminated California NCT00282841
Vitamin D and Omega-3 Trial (VITAL) Active, Not Recruiting Massachusetts NCT01169259
Vitamin Therapy for Prevention of Stroke Stroke Completed North Carolina NCT00004734
Volitional Swallowing in Stroke Patients With Chronic Dysphagia Stroke Completed Maryland NCT00306501
Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial Stroke Completed Multiple U.S. Locations NCT00041938
Warfarin Versus Aspirin Recurrent Stroke Study Stroke Completed New York NCT00027066
Warfighter Head Injury Study Terminated Maryland NCT00754169
Wearable Sensor for Responsive DBS for ET Essential Tremor Completed Florida NCT03051178
Wireless Nerve Stimulation Device To Enhance Recovery After Stroke Stroke Recruiting Texas NCT04534556
Wolman/CESD Natural History Chart Review and Longitudinal Follow-Up Completed Ohio NCT01884220
Women's Estrogen for Stroke Trial (WEST) Stroke Completed NCT00026039
Zenapax (Daclizumab) to Treat Relapsing Remitting Multiple Sclerosis Completed Maryland NCT00071838